Rezultati - Ray D. Page

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Opioids and Cancer Pain: Patients’ Needs and Access Challenges

    Opioids and Cancer Pain: Patients’ Needs and Access Challenges od Ray D. Page, Elizabeth Blanchard

    Izdano 2019
    Polni tekst Polni tekst
    Editorial
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Primary hepatic lymphoma

    Primary hepatic lymphoma od Ray D. Page, Jorge Romaguera, Barbara M. Osborne, L. Jeffrey Medeiros, José Rodríguez, L North, César Sanz-Rodrı́guez, Fernando Cabanillas

    Izdano 2001
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer

    Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer od Mark A. Socinski, Corey J. Langer, Isamu Okamoto, Jeremy K. Hon, Vera Hirsh, Shaker R. Dakhil, Ray D. Page, James Orsini, H. Zhang, Markus F. Renschler

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer

    Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer od Nuhad K. Ibrahim, Brian L. Samuels, Ray D. Page, Dinesh Chandra Doval, Kirtikumar M. Patel, Sujaya Rao, Madhavan Krishnan Nair, Paul Bhar, Neil Desai, Gabriel N. Hortobágyi

    Izdano 2005
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer

    Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer od Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona‐Calero, Daniel Dix, Justin I. Odegaard, Richard B. Lanman, Vassiliki A. Papadimitrakopoulou

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Telehealth in Oncology: ASCO Standards and Practice Recommendations

    Telehealth in Oncology: ASCO Standards and Practice Recommendations od Robin Zoň, Erin B. Kennedy, Kerin B. Adelson, Sibel Blau, N Dickson, David Gill, Nicole Laferriere, Ana María López, Therese M. Mulvey, Debra A. Patt, Todd Pickard, Terry Purdom, Trevor J. Royce, Ashley Sumrall, Ray D. Page

    Izdano 2021
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    P3.02c-026 Is Nivolumab Safe and Effective in Elderly and PS2 Patients with Non-Small Cell Lung Cancer (NSCLC)? Results of CheckMate 153

    P3.02c-026 Is Nivolumab Safe and Effective in Elderly and PS2 Patients with Non-Small Cell Lung Cancer (NSCLC)? Results of CheckMate 153 od David R. Spigel, Lee S. Schwartzberg, David Waterhouse, Jason C. Chandler, Maen Hussein, Robert M. Jotte, Edward J. Stepanski, Michael McCleod, Ray D. Page, Rohini Sen, Jeffrey G. McDonald, Kelly L. Bennett, Beata Korytowsky, Nivedita Aanur, Craig H. Reynolds

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

    Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC od Jennifer J. Knox, Carlos H. Barrios, T.M. Kim, Thomas M. Cosgriff, Vichien Srimuninnimit, K. Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W. Flaig, Ray D. Page, J. Thaddeus Beck, Florence Cheung, S. Yadav, Poulam M. Patel, Lionnel Geoffrois, Julie Niolat, Noah Berkowitz, Mahtab Marker, Dehui Chen, Robert J. Motzer

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma

    Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Re... od Robert J. Motzer, Carlos H. Barrios, Tae Min Kim, S. Falcon, Thomas M. Cosgriff, W G Harker, Vichien Srimuninnimit, Ken Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W. Flaig, Ray D. Page, Sevil Bavbek, J. Thaddeus Beck, Poulam M. Patel, F.Y. Cheung, Sunil Kumar Yadav, Edward Schiff, Xufang Wang, Julie Niolat, Dalila Sellami, Oezlem Anak, Jennifer J. Knox

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

    PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer od Hui Yu, Cory Batenchuk, A. Badzio, Theresa A. Boyle, Piotr Czapiewski, Daniel C. Chan, Xian Lu, Dexiang Gao, Kim Ellison, Ashley Kowalewski, Christopher J. Rivard, Rafał Dziadziuszko, Caicun Zhou, Maen Hussein, Donald Richards, Sharon Wilks, Marc Monte, William J. Edenfield, Jerome H. Goldschmidt, Ray D. Page, Brian Ulrich, David Waterhouse, Sandra Close, Jacek Jassem, Kimary Kulig, Fred R. Hirsch

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: